Product
Sodium stibogluconate + Paramomycin
1 clinical trial
1 indication
Indication
Visceral LeishmaniasisClinical trial
A Multicentre Observational Study to Assess Immune Response Status in Patients Before and After Treatment for Visceral LeishmaniasisStatus: Recruiting, Estimated PCD: 2024-11-01